The AIM All Share started with some good gains but tailed off during the session, finishing the day a quarter of a point lower at 720.74.
- GENinCode +72%
- Empyrean +47%
- Watkin Jones +26%
- Proton Motors -42%
- Enwell Energy -26%
GENinCode LON:GENI topped the board on Thursday, adding 72% on the day. The company released an update this morning regarding its inclusion in US clinical lab fee structures, paving the way for a solid revenue stream from across the Atlantic.
Empyrean LON:EME was 47% higher after noting it has successfully completed the acquisition of an option to participate in a conventional oil exploration project from Apnea Holdings Pty Ltd. Drilling is scheduled for March. It’s believed there’s in the region of 20MMBOE of oil in place and the option allows Empyrean to earn a minimum of 40%.
- Small Cap Stocks: Empyrean, Seascape, Mirriad
- Small Cap Stocks: Empyrean, Beacon Energy, Bushveld Minerals
Watkin Jones LON:WJG was 26% higher to take the notable mention. Their full year results were out this morning and despite a 15% fall in revenues, operating profits soared reflecting a series of shifts in the business. The outlook remains strong.
Proton Motors LON:PPS was the biggest faller, off 42% on the day. There’s no news here but the company continues to plot its way to a delisting.
- AIM Market Roundup: Marechale, Oxford Biodynamics, SDX Energy
- AIM Market Roundup: Engage XR, Lunglife, Greatland Gold
Enwell Energy LON:ENW was 26% lower after operating licenses were suspended again. That’s just a couple of months since the Ukrainian authorities reversed a previous suspension> legal proceedings in a bid to recover the situation continue.